From left: Mr. Sean Kirk, Founder & CEO of Rehouzd, and Mr. Ragul Shanmugam, Co-Founder & CTO of Rehouzd.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The White House has denied that President Donald Trump was given an ...

The White House has denied that President Donald Trump was given an experimental new obesity drug through the Food and Drug Administration’s (FDA) “compassionate use” program. Trump, 80, became the ...

White House officials on Tuesday shot down a report speculating President Trump gained access to the retatrutide weight loss drug under the Food and Drug Administration’s (FDA) “compassionate use ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

Video shows TN minister crushing white powder at IPL match Minister says he was crushing medicine for his sick daughter Clip sparks drug use allegations and calls for resignation Tamil Nadu Minister ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

When Sunthar Vykunthanathan started stand-up comedy about eight years ago, he performed mostly in English. But he decided to switch it up when he noticed a big portion of his audience was Tamil. “The ...

"This application was not for the President," White House spokesman Kush Desai wrote on X about viral rumors regarding Trump's alleged use of retatrutide Becca Longmire is a digital news ...

US President Donald Trump speaks to the press after stepping off Air Force One at Reading Regional Airport on June 23, 2026. Eli Lilly and the Food and Drug Administration allowed a person to have ...